CALGB 50604: risk-adapted treatment of nonbulky early-stage Hodgkin lymphoma based on interim PET
- Citation:
- Blood vol 132 (10) 1013-21
- Year:
- 2018
- Type:
- Manuscript
- Funding:
- NCTN
- Endpoint:
- Primary
- Analysis:
- Primary
- Data Sharing:
- No-Data-Sharing
- Status:
- Presented/Published
- Citation Status:
- ppub
- Note:
- Methodological:
- No
- Biospecimen:
- No
- SDC:
- No
- Book Volume:
- 8
- Parents:
- 2385
- Children:
- None
- Pharmas:
- Grants:
- U10CA180821, U10CA180882, U10CA007968, U10CA077597, U10CA077651, U10CA077658, U10CA180791, U10CA180833, U10CA180850, U10CA180820 (ECOG-ACRIN), U10CA180888 (SWOG).
- Corr. Author:
- Authors:
- David J. Straus Sin-Ho Jung Brandelyn Pitcher Lale Kostakoglu John C. Grecula Eric D. Hsi Heiko Schöder Leslie L. Popplewell Julie E. Chang Craig H. Moskowitz Nina Wagner-Johnston John P. Leonard Jonathan W. Friedberg Brad S. Kahl Bruce D. Cheson Nancy L. Bartlett
- Networks:
- CA043, CAPITAL, FL028, LAPS-MD017, LAPS-MN026, LAPS-MO011, LAPS-NY016, LAPS-OH007, LAPS-WI020, NY018, PA121, VA009
- Study
- CALGB-50604
- Multiple Studies, or Legacy Studies in Alliance Study:
- Phases:
- 2
- Keywords: